The Odds
DIFFERENTIATED
APPROACH
We are continuously evaluating innovative ways to overcome deadly and difficult-to-treat diseases.
Our ScienceACCELERATING
INNOVATION
Learn more about Chimerix’s approach to investing in novel drug candidates that meaningfully improve the probability of survival and the collaborative team driving the development of these promising new therapies.
About UsOUR
COMMITMENT
Chimerix is focused on identifying and developing new oncology and biodefense therapies to rewrite the odds for patients.
Our FocusNEWS
view all- Chimerix Presents Data Supporting Brincidofovir as a Potential Treatment for Smallpox at 2020 American Society for Microbiology Biothreats Meeting
- Chimerix Presents Updated Results from Phase 2 Clinical Trial of DSTAT in Refractory Myelodysplastic Syndrome and Acute Myeloid Leukemia at American Society of Hematology Annual Meeting